ADMA Biologics, Inc.ADMANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-39.9%
5Y CAGR-14.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-39.9%/yr
Annual compound
5Y CAGR
-14.8%/yr
Recent deceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 19.63% |
| 2024 | 65.15% |
| 2023 | 67.59% |
| 2022 | 90.36% |
| 2021 | 91.72% |
| 2020 | 43.85% |
| 2019 | 72.79% |
| 2018 | -25.37% |
| 2017 | 113.49% |
| 2016 | 48.53% |